March 17, 2021 Quanterix’ Simoa Technology Accelerates Critical Plasma Biomarker Research Presented at the 15th International Conference on Parkinson’s & Alzheimer’s Disease (AD/PDTM 2021) read more
March 2, 2021 Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2020 read more
February 23, 2021 Quanterix Corporation To Release Fourth Quarter And Full Year 2020 Financial Results On March 2, 2021 read more
February 8, 2021 Quanterix Announces Closing of Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares read more
February 3, 2021 Quanterix Announces Proposed Public Offering of $200.0 Million of its Common Stock read more
January 11, 2021 Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test read more